143 related articles for article (PubMed ID: 19409799)
21. Planned fractionated boron neutron capture therapy using epithermal neutrons for a patient with recurrent squamous cell carcinoma in the temporal bone: a case report.
Haginomori S; Miyatake S; Inui T; Araki M; Kawabata S; Takamaki A; Lee K; Takenaka H; Kuroiwa T; Uesugi Y; Kumada H; Ono K
Head Neck; 2009 Mar; 31(3):412-8. PubMed ID: 18767175
[TBL] [Abstract][Full Text] [Related]
22. A comparison of dose distributions in gross tumor volume between boron neutron capture therapy alone and combined boron neutron capture therapy plus intensity modulation radiation therapy for head and neck cancer.
Lee JC; Chuang KS; Hsueh Liu YW; Lin TY; Teng YC; Wang LW
PLoS One; 2019; 14(4):e0210626. PubMed ID: 30947267
[TBL] [Abstract][Full Text] [Related]
23. BNCT for locally recurrent head and neck cancer: preliminary clinical experience from a phase I/II trial at Tsing Hua Open-Pool Reactor.
Wang LW; Wang SJ; Chu PY; Ho CY; Jiang SH; Liu YW; Liu YH; Liu HM; Peir JJ; Chou FI; Yen SH; Lee YL; Chang CW; Liu CS; Chen YW; Ono K
Appl Radiat Isot; 2011 Dec; 69(12):1803-6. PubMed ID: 21478023
[TBL] [Abstract][Full Text] [Related]
24. Designation Products: Boron Neutron Capture Therapy for Head and Neck Carcinoma.
Kanno H; Nagata H; Ishiguro A; Tsuzuranuki S; Nakano S; Nonaka T; Kiyohara K; Kimura T; Sugawara A; Okazaki Y; Takae S; Nakabayashi T; Arai H; Suzuki H
Oncologist; 2021 Jul; 26(7):e1250-e1255. PubMed ID: 33928712
[TBL] [Abstract][Full Text] [Related]
25. Survival benefit of Boron neutron capture therapy for recurrent malignant gliomas.
Miyatake S; Kawabata S; Yokoyama K; Kuroiwa T; Michiue H; Sakurai Y; Kumada H; Suzuki M; Maruhashi A; Kirihata M; Ono K
J Neurooncol; 2009 Jan; 91(2):199-206. PubMed ID: 18813875
[TBL] [Abstract][Full Text] [Related]
26. Clinical potential of boron neutron capture therapy for locally recurrent inoperable previously irradiated head and neck cancer.
Lim D; Quah DS; Leech M; Marignol L
Appl Radiat Isot; 2015 Dec; 106():237-41. PubMed ID: 26277052
[TBL] [Abstract][Full Text] [Related]
27. Survival benefit of boron neutron capture therapy for recurrent malignant gliomas.
Miyatake S; Kawabata S; Yokoyama K; Kuroiwa T; Michiue H; Sakurai Y; Kumada H; Suzuki M; Maruhashi A; Kirihata M; Onoc K
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S22-4. PubMed ID: 19394240
[TBL] [Abstract][Full Text] [Related]
28. Validation of nomogram-based prediction of survival probability after salvage re-irradiation of head and neck cancer.
Shikama N; Kumazaki Y; Tsukamoto N; Ebara T; Makino S; Abe T; Nakahira M; Sugasawa M; Kato S
Jpn J Clin Oncol; 2013 Feb; 43(2):154-60. PubMed ID: 23242582
[TBL] [Abstract][Full Text] [Related]
29. Delivery of (10)boron to oral squamous cell carcinoma using boronophenylalanine and borocaptate sodium for boron neutron capture therapy.
Obayashi S; Kato I; Ono K; Masunaga S; Suzuki M; Nagata K; Sakurai Y; Yura Y
Oral Oncol; 2004 May; 40(5):474-82. PubMed ID: 15006618
[TBL] [Abstract][Full Text] [Related]
30. [Results of neutron therapy in recurrent malignant salivary gland tumors in the head and neck area].
Krüll A; Schwarz R; Heyer D; Timm H; Schmidt R
Strahlenther Onkol; 1995 May; 171(5):265-71. PubMed ID: 7770781
[TBL] [Abstract][Full Text] [Related]
31. Preliminary outcomes of boron neutron capture therapy for head and neck cancers as a treatment covered by public health insurance system in Japan: Real-world experiences over a 2-year period.
Takeno S; Yoshino Y; Aihara T; Higashino M; Kanai Y; Hu N; Kakino R; Kawata R; Nihei K; Ono K
Cancer Med; 2024 Jun; 13(11):e7250. PubMed ID: 38826090
[TBL] [Abstract][Full Text] [Related]
32. Submandibular gland-sparing intensity modulated radiotherapy in the treatment of head and neck cancer: sites of locoregional relapse and survival.
Collan J; Kapanen M; Mäkitie A; Nyman H; Joensuu H; Tenhunen M; Saarilahti K
Acta Oncol; 2012 Jul; 51(6):735-42. PubMed ID: 22150115
[TBL] [Abstract][Full Text] [Related]
33. Modified boron neutron capture therapy for malignant gliomas performed using epithermal neutron and two boron compounds with different accumulation mechanisms: an efficacy study based on findings on neuroimages.
Miyatake S; Kawabata S; Kajimoto Y; Aoki A; Yokoyama K; Yamada M; Kuroiwa T; Tsuji M; Imahori Y; Kirihata M; Sakurai Y; Masunaga S; Nagata K; Maruhashi A; Ono K
J Neurosurg; 2005 Dec; 103(6):1000-9. PubMed ID: 16381186
[TBL] [Abstract][Full Text] [Related]
34. First clinical case of boron neutron capture therapy for head and neck malignancies using 18F-BPA PET.
Aihara T; Hiratsuka J; Morita N; Uno M; Sakurai Y; Maruhashi A; Ono K; Harada T
Head Neck; 2006 Sep; 28(9):850-5. PubMed ID: 16721735
[TBL] [Abstract][Full Text] [Related]
35. BNCT of 3 cases of spontaneous head and neck cancer in feline patients.
Rao M; Trivillin VA; Heber EM; Cantarelli Mde L; Itoiz ME; Nigg DW; Rebagliati RJ; Batistoni D; Schwint AE
Appl Radiat Isot; 2004 Nov; 61(5):947-52. PubMed ID: 15308173
[TBL] [Abstract][Full Text] [Related]
36. Boron neutron capture therapy for recurrent malignant meningioma. Case report.
Tamura Y; Miyatake S; Nonoguchi N; Miyata S; Yokoyama K; Doi A; Kuroiwa T; Asada M; Tanabe H; Ono K
J Neurosurg; 2006 Dec; 105(6):898-903. PubMed ID: 17405262
[TBL] [Abstract][Full Text] [Related]
37. PET pharmacokinetic analysis to estimate boron concentration in tumor and brain as a guide to plan BNCT for malignant cerebral glioma.
Nariai T; Ishiwata K; Kimura Y; Inaji M; Momose T; Yamamoto T; Matsumura A; Ishii K; Ohno K
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S348-50. PubMed ID: 19375930
[TBL] [Abstract][Full Text] [Related]
38. Combination of surgical resection and HDR-brachytherapy in patients with recurrent or advanced head and neck carcinomas.
Schiefke F; Hildebrandt G; Pohlmann S; Heinicke F; Hemprich A; Frerich B
J Craniomaxillofac Surg; 2008 Jul; 36(5):285-92. PubMed ID: 18353667
[TBL] [Abstract][Full Text] [Related]
39. Recurrences near base of skull after IMRT for head-and-neck cancer: implications for target delineation in high neck and for parotid gland sparing.
Eisbruch A; Marsh LH; Dawson LA; Bradford CR; Teknos TN; Chepeha DB; Worden FP; Urba S; Lin A; Schipper MJ; Wolf GT
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):28-42. PubMed ID: 15093896
[TBL] [Abstract][Full Text] [Related]
40. Stereotactic body radiotherapy for recurrent squamous cell carcinoma of the head and neck: results of a phase I dose-escalation trial.
Heron DE; Ferris RL; Karamouzis M; Andrade RS; Deeb EL; Burton S; Gooding WE; Branstetter BF; Mountz JM; Johnson JT; Argiris A; Grandis JR; Lai SY
Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1493-500. PubMed ID: 19464819
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
